Matthew Ocko

Matthew Ocko has an estimated net worth of $246 Million. This is based on reported shares across multiple companies, which include RECURSION PHARMACEUTICALS, INC., Embark Technology, Inc., AbCellera Biologics Inc., Rocket Lab Corp, and Zymergen Inc..

2021 was Matthew Ocko's most active year for acquiring shares with 13 total transactions. Matthew Ocko's most active month to acquire stocks was the month of March. 2025 was Matthew Ocko's most active year for disposing of shares, totalling 20 transactions. Matthew Ocko's most active month to dispose stocks was the month of August. 2022 saw Matthew Ocko paying a total of $314,921.60 for 142,000 shares, this is the most they've acquired in one year. In 2024 Matthew Ocko cashed out on 5,366,193 shares for a total of $96,765,249.16, their largest year based on trade value.